META MATERIALS INC (MMAT)
US59134N3026 - Common Stock
Taking everything into account, MMAT scores 2 out of 10 in our fundamental rating. MMAT was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of MMAT have multiple concerns. MMAT is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year MMAT has reported negative net income.
In the past year MMAT has reported a negative cash flow from operations.
MMAT had negative earnings in each of the past 5 years.
MMAT had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
MMAT's Return On Assets of -834.91% is on the low side compared to the rest of the industry. MMAT is outperformed by 99.07% of its industry peers.
MMAT has a Return On Equity of -2111.11%. This is amonst the worse of the industry: MMAT underperforms 93.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -834.91% | ||
| ROE | -2111.11% | ||
| ROIC | N/A |
ROA(3y)-253.79%
ROA(5y)-164.97%
ROE(3y)-621.14%
ROE(5y)-405.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 66.75%, MMAT belongs to the top of the industry, outperforming 87.96% of the companies in the same industry.
MMAT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for MMAT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.75% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y183.27%
GM growth 5Y9.66%
2. Health
2.1 Basic Checks
MMAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
MMAT has more shares outstanding than it did 1 year ago.
The number of shares outstanding for MMAT has been increased compared to 5 years ago.
The debt/assets ratio for MMAT is higher compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of -21.34, we must say that MMAT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of MMAT (-21.34) is worse than 86.11% of its industry peers.
A Debt/Equity ratio of 0.16 indicates that MMAT is not too dependend on debt financing.
The Debt to Equity ratio of MMAT (0.16) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -21.34 |
ROIC/WACCN/A
WACC11.52%
2.3 Liquidity
A Current Ratio of 0.58 indicates that MMAT may have some problems paying its short term obligations.
MMAT has a Current ratio of 0.58. This is amonst the worse of the industry: MMAT underperforms 95.37% of its industry peers.
A Quick Ratio of 0.57 indicates that MMAT may have some problems paying its short term obligations.
MMAT has a worse Quick ratio (0.57) than 92.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.57 |
3. Growth
3.1 Past
MMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.87%, which is quite impressive.
Looking at the last year, MMAT shows a quite strong growth in Revenue. The Revenue has grown by 13.75% in the last year.
Measured over the past years, MMAT shows a very strong growth in Revenue. The Revenue has been growing by 44.10% on average per year.
EPS 1Y (TTM)36.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%76.6%
Revenue 1Y (TTM)13.75%
Revenue growth 3Y245.59%
Revenue growth 5Y44.1%
Sales Q2Q%131.54%
3.2 Future
MMAT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.10% yearly.
The Revenue is expected to grow by 175.50% on average over the next years. This is a very strong growth
EPS Next Y25.62%
EPS Next 2Y41.4%
EPS Next 3Y26.1%
EPS Next 5YN/A
Revenue Next Year312.22%
Revenue Next 2Y289.54%
Revenue Next 3Y175.51%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MMAT. In the last year negative earnings were reported.
Also next year MMAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
MMAT's earnings are expected to grow with 26.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.4%
EPS Next 3Y26.1%
5. Dividend
5.1 Amount
MMAT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
META MATERIALS INC
NASDAQ:MMAT (6/17/2024, 7:00:00 PM)
After market: 3.13 +0.08 (+2.62%)3.05
-0.09 (-2.87%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap19.31M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -834.91% | ||
| ROE | -2111.11% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.75% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.21
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.16 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 0.58 | ||
| Quick Ratio | 0.57 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)36.87%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y25.62%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)13.75%
Revenue growth 3Y245.59%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y